| Dr Michael R Dawdy, MD | |
|
20333 W 151st St, Olathe, KS 66061-5350 | |
| (913) 791-4357 | |
| (913) 791-4435 |
| Full Name | Dr Michael R Dawdy |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 20333 W 151st St, Olathe, Kansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1831207471 | NPI | - | NPPES |
| 103527 | Other | KS | UHC |
| 26758059 | Other | KS | BCBSKC |
| 100364160B | Medicaid | KS | |
| 1831207471 | Medicaid | MO | |
| 26758029 | Other | BCBSKC | |
| 930113107 | Other | KS | RR MEDICARE |
| 100364160C | Medicaid | KS | |
| 7846200 | Other | KS | AETNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 04-28089 (Kansas) | Primary |
| 207PE0005X | Emergency Medicine - Undersea And Hyperbaric Medicine | 0428089 (Kansas) | Secondary |
| Entity Name | Emergency Medicine Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356455752 PECOS PAC ID: 0941272231 Enrollment ID: O20051114001205 |
News Archive
Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.
For severely obese people, bariatric surgery may have a benefit besides dramatic weight loss: it can also substantially reduce urinary incontinence.
A team of Italian scientists reported this week that blocking the interaction between urokinase receptor (uPAR) and formyl peptide receptor type 1 (FPR1) suppresses the ability of melanoma cells to migrate, invade through an extracellular matrix, and to burrow through a layer of endothelial cells.
Intralytix, Inc. announced today that it has received regulatory clearance from the Food and Drug Administration for its phage-based EcoShield food safety product, effective against E. coli O157:H7.
Transplant surgeons at Johns Hopkins who have reviewed the medical records of more than 20,000 heart transplant patients say that it is not simply racial differences, but rather flaws in the health care system, along with type of insurance and education levels, in addition to biological factors, that are likely the causes of disproportionately worse outcomes after heart transplantation in African Americans.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael R Dawdy, MD Po Box 716, Overland Park, KS 66201-0716 Ph: (913) 791-4357 | Dr Michael R Dawdy, MD 20333 W 151st St, Olathe, KS 66061-5350 Ph: (913) 791-4357 |
News Archive
Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.
For severely obese people, bariatric surgery may have a benefit besides dramatic weight loss: it can also substantially reduce urinary incontinence.
A team of Italian scientists reported this week that blocking the interaction between urokinase receptor (uPAR) and formyl peptide receptor type 1 (FPR1) suppresses the ability of melanoma cells to migrate, invade through an extracellular matrix, and to burrow through a layer of endothelial cells.
Intralytix, Inc. announced today that it has received regulatory clearance from the Food and Drug Administration for its phage-based EcoShield food safety product, effective against E. coli O157:H7.
Transplant surgeons at Johns Hopkins who have reviewed the medical records of more than 20,000 heart transplant patients say that it is not simply racial differences, but rather flaws in the health care system, along with type of insurance and education levels, in addition to biological factors, that are likely the causes of disproportionately worse outcomes after heart transplantation in African Americans.
› Verified 6 days ago
Bharat Sutariya, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4357 Fax: 913-791-4435 | |
Jesmin P. Ehlers, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4357 Fax: 913-791-4435 | |
Chris C Davlantes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4357 Fax: 913-791-4435 | |
Stephanee Evers, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4357 Fax: 913-791-4435 | |
Michael J Reilly, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4357 Fax: 913-791-4435 | |
Melina Keithly, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4357 Fax: 913-791-4435 | |
Shawn M. Stanley, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4357 |